HUP0104513A3 - Powders of improved quality - Google Patents

Powders of improved quality

Info

Publication number
HUP0104513A3
HUP0104513A3 HU0104513A HUP0104513A HUP0104513A3 HU P0104513 A3 HUP0104513 A3 HU P0104513A3 HU 0104513 A HU0104513 A HU 0104513A HU P0104513 A HUP0104513 A HU P0104513A HU P0104513 A3 HUP0104513 A3 HU P0104513A3
Authority
HU
Hungary
Prior art keywords
powders
improved quality
quality
improved
Prior art date
Application number
HU0104513A
Other languages
English (en)
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of HUP0104513A2 publication Critical patent/HUP0104513A2/hu
Publication of HUP0104513A3 publication Critical patent/HUP0104513A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Carbon And Carbon Compounds (AREA)
HU0104513A 1998-12-09 1999-12-09 Powders of improved quality HUP0104513A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9827145.5A GB9827145D0 (en) 1998-12-09 1998-12-09 Improvements in or relating to powders
PCT/GB1999/004156 WO2000033811A2 (en) 1998-12-09 1999-12-09 Improvements in or relating to powders

Publications (2)

Publication Number Publication Date
HUP0104513A2 HUP0104513A2 (hu) 2002-03-28
HUP0104513A3 true HUP0104513A3 (en) 2003-12-29

Family

ID=10843948

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104513A HUP0104513A3 (en) 1998-12-09 1999-12-09 Powders of improved quality

Country Status (24)

Country Link
US (1) US6989155B1 (hu)
EP (1) EP1137399B1 (hu)
JP (1) JP4410942B2 (hu)
KR (1) KR20010101138A (hu)
CN (1) CN1334723A (hu)
AT (1) ATE240093T1 (hu)
AU (1) AU770461B2 (hu)
BR (1) BR9916102A (hu)
CA (1) CA2353448C (hu)
CZ (1) CZ20012043A3 (hu)
DE (1) DE69907951T2 (hu)
DK (1) DK1137399T3 (hu)
EA (1) EA004045B1 (hu)
ES (1) ES2198973T3 (hu)
GB (1) GB9827145D0 (hu)
HU (1) HUP0104513A3 (hu)
MX (1) MXPA01005584A (hu)
NO (1) NO20012825D0 (hu)
NZ (1) NZ511965A (hu)
PL (1) PL348831A1 (hu)
PT (1) PT1137399E (hu)
SK (1) SK284775B6 (hu)
TR (1) TR200101591T2 (hu)
WO (1) WO2000033811A2 (hu)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
ES2526707T3 (es) 1999-06-29 2015-01-14 Mannkind Corporation Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
JP2001151673A (ja) * 1999-09-06 2001-06-05 Nikken Chem Co Ltd 吸入用粉末製剤の製造方法
DK1296651T3 (da) * 2000-06-27 2008-02-11 Vectura Ltd Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat
US7744855B2 (en) 2000-06-27 2010-06-29 Vectura Limited Method of making particles for use in a pharmaceutical composition
ES2334642T5 (es) * 2000-11-30 2016-03-07 Vectura Limited Partículas para usar en una composición farmacéutica
EP2298279B1 (en) 2000-11-30 2018-11-14 Vectura Limited Pharmaceutical compositions for inhalation
AU2002222118A1 (en) 2000-11-30 2002-06-11 Vectura Limited Pharmaceutical compositions for inhalation
SI1494732T1 (sl) 2002-03-20 2008-08-31 Mannking Corp Inhalacijski aparat
AU2003230689B2 (en) * 2002-03-20 2006-06-29 Alkermes, Inc. Inhalable sustained therapeutic formulations
CA2478327A1 (en) * 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Hgh (human growth hormone) formulations for pulmonary administration
US7754242B2 (en) 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US20110123574A1 (en) * 2002-03-20 2011-05-26 Alkermes, Inc. Inhalable sustained therapeutic formulations
US20060178394A1 (en) * 2003-04-14 2006-08-10 Staniforth John N Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
JP5078014B2 (ja) 2004-08-20 2012-11-21 マンカインド コーポレイション ジケトピペラジン合成の触媒反応
HUE025151T2 (hu) 2004-08-23 2016-01-28 Mannkind Corp Diketo-piperazin-sók gyógyszeradagolás céljára
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
CN104177448A (zh) 2005-02-10 2014-12-03 葛兰素集团有限公司 使用预分选技术制备乳糖的方法以及由此形成的药物制剂
CA2617909C (en) * 2005-08-05 2014-02-04 3M Innovative Properties Company Compositions exhibiting improved flowability
EP1928423B1 (en) 2005-09-14 2015-12-09 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
GB0525254D0 (en) 2005-12-12 2006-01-18 Jagotec Ag Powder compositions for inhalation
EP1986679B1 (en) * 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
DE102006030164A1 (de) * 2006-06-29 2008-01-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Pulver
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
US20090048155A1 (en) 2007-08-15 2009-02-19 Endacea, Inc. Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection
US8785396B2 (en) * 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
US9522916B2 (en) 2007-12-21 2016-12-20 Constance Neely Wilson A1 adenosine receptor antagonists
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101558026B1 (ko) 2008-06-13 2015-10-06 맨카인드 코포레이션 건조 분말 흡입기 및 약물 투여 시스템
CA2728523C (en) 2008-06-20 2020-03-10 Mannkind Corporation An interactive apparatus and method for real-time profiling of inhalation efforts
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP3578169A1 (en) 2009-02-26 2019-12-11 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
EP2440184B1 (en) 2009-06-12 2023-04-05 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
US9877967B2 (en) 2010-01-26 2018-01-30 Endacea, Inc. Methods and pharmaceutical compositions for preventing and treating renal impairment
CA2801936C (en) 2010-06-21 2021-06-01 Mannkind Corporation Dry powder drug delivery system and methods
US8758824B2 (en) * 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
RU2017144619A (ru) 2010-09-29 2019-02-20 Пулмэтрикс, Инк. Катионы одновалентных металлов сухих порошков для ингаляций
AU2015249177B2 (en) * 2010-11-09 2017-08-03 Mannkind Corporation Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
WO2012064892A1 (en) * 2010-11-09 2012-05-18 Mannkind Corporation Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
KR101940832B1 (ko) 2011-04-01 2019-01-21 맨카인드 코포레이션 의약 카트리지용 블리스터 패키지
RU2448717C1 (ru) * 2011-04-20 2012-04-27 Закрытое акционерное общество Научно-производственное предприятие "Тринита" Способ получения антикоагулянтно-фибринолитического средства на основе гепарина
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2776053A1 (en) 2011-10-24 2014-09-17 MannKind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
WO2014106727A1 (en) 2013-01-03 2014-07-10 Vectura Limited Inhaler and formulation
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
AU2014248455B2 (en) 2013-04-01 2018-12-06 Pulmatrix Operating Company, Inc. Tiotropium dry powders
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
WO2018005552A1 (en) 2016-06-27 2018-01-04 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
MX2019010263A (es) * 2017-03-07 2019-10-09 Philip Morris Products Sa Formulaciones de nicotina inhalables y metodos de fabricacion y uso de las mismas.
WO2019118370A1 (en) * 2017-12-12 2019-06-20 Xotramorphic, Llc Compositions, methods, and systems for producing flocculent materials for special effects
CN111902141A (zh) 2018-03-26 2020-11-06 C4医药公司 用于ikaros降解的羟脑苷脂结合剂
CN110441198A (zh) * 2018-05-03 2019-11-12 人福普克药业(武汉)有限公司 一种检测尼达尼布软胶囊中尼达尼布粒径的方法
JP2021535112A (ja) 2018-08-20 2021-12-16 アキリオン ファーマシューティカルズ,インコーポレーテッド 補体d因子の医学的障害の治療のための医薬化合物
EP3866773A4 (en) 2018-10-16 2022-10-26 Georgia State University Research Foundation, Inc. CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL CONDITIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE69634246T2 (de) 1995-04-14 2006-01-12 Nektar Therapeutics, San Carlos Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
PT1666028E (pt) * 1999-10-29 2010-06-15 Novartis Ag Composições de pós anidros com melhor dispersividade

Also Published As

Publication number Publication date
EA004045B1 (ru) 2003-12-25
CN1334723A (zh) 2002-02-06
ATE240093T1 (de) 2003-05-15
WO2000033811A3 (en) 2000-10-12
NO20012825L (no) 2001-06-08
PL348831A1 (en) 2002-06-17
CZ20012043A3 (cs) 2001-12-12
EP1137399B1 (en) 2003-05-14
ES2198973T3 (es) 2004-02-01
DE69907951D1 (de) 2003-06-18
AU770461B2 (en) 2004-02-19
PT1137399E (pt) 2003-09-30
US6989155B1 (en) 2006-01-24
SK7772001A3 (en) 2001-12-03
NZ511965A (en) 2003-09-26
KR20010101138A (ko) 2001-11-14
EA200100636A1 (ru) 2001-12-24
WO2000033811A2 (en) 2000-06-15
DE69907951T2 (de) 2004-03-11
GB9827145D0 (en) 1999-02-03
DK1137399T3 (da) 2003-08-18
CA2353448C (en) 2010-02-23
EP1137399A2 (en) 2001-10-04
NO20012825D0 (no) 2001-06-08
SK284775B6 (sk) 2005-11-03
JP4410942B2 (ja) 2010-02-10
CA2353448A1 (en) 2000-06-15
JP2002531487A (ja) 2002-09-24
TR200101591T2 (tr) 2001-11-21
HUP0104513A2 (hu) 2002-03-28
MXPA01005584A (es) 2003-07-14
BR9916102A (pt) 2001-09-04
AU1577700A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
HUP0104513A3 (en) Powders of improved quality
IL129906A0 (en) Process for the preparation of beta-isophorone
PL341648A1 (en) Novel method of obtaining kethymin
PL330480A1 (en) Antimycotic composition of enhanced bioavailability
PL342733A1 (en) Biocement of improved properties
GB2327623B (en) Powder production
HUP9902855A3 (en) Preparation of sterol- and stanol-esters
HUP9902745A2 (en) Process for the preparation of benzylcarbazate
IL124920A0 (en) Manufacture of boxes
GB2319782B (en) Iron based powder
GB2337822B (en) Material characterisation
GB9802487D0 (en) Production of heptafluoropane
HUP0103672A3 (en) Process for preparation of exochelins
GB9806731D0 (en) Metal powder
GB9827612D0 (en) Encription of digital video
TW354479U (en) Improvement of earpick
GB9815290D0 (en) Improved powder composition
GB9818917D0 (en) Manufacture of paper
GB9816680D0 (en) Talcum powder composition
TW400927U (en) Improvement of screw
GB9816533D0 (en) Preparation of heterocyclic thiols
TW370097U (en) Modification of material cart
AU1830P (en) Powder Puff Rosa banksiae
CA83885S (en) Set of screens
CA83884S (en) Set of screens